These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6337787)

  • 21. Long-term oral treatment with high doses of verapamil in lone atrial fibrillation.
    Johansson PA; Olsson SB
    Clin Cardiol; 1984 Mar; 7(3):163-70. PubMed ID: 6705301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness of diltiazem in controlling ventricular response and improving exercise capacity in chronic atrial fibrillation. Double-blind, cross-over study].
    Vitale P; Auricchio A; De Stefano R; Agretto A; De Simone R; Vitale N; Barbato F; Iacono A
    Cardiologia; 1989 Jan; 34(1):73-81. PubMed ID: 2720716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of digoxin effect in atrial fibrillation.
    Zener JC; Anggard EE; Harrison DC; Kalman SM
    JAMA; 1973 Apr; 224(2):239-41. PubMed ID: 4739495
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of chronic atrial fibrillation in the elderly, assessed by ambulatory electrocardiographic monitoring.
    Wang R; Camm J; Ward D; Washington H; Martin A
    J Am Geriatr Soc; 1980 Dec; 28(12):529-34. PubMed ID: 7430528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evidence regarding the drugs used for ventricular rate control.
    Segal JB; McNamara RL; Miller MR; Kim N; Goodman SN; Powe NR; Robinson K; Yu D; Bass EB
    J Fam Pract; 2000 Jan; 49(1):47-59. PubMed ID: 10678340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillation.
    Lewis RV; McDevitt DG
    Br J Clin Pharmacol; 1988 May; 25(5):603-6. PubMed ID: 3044426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.
    Lewis RV; McMurray J; McDevitt DG
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):1-6. PubMed ID: 2468920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diltiazem as adjunctive oral therapy in patients with chronic atrial fibrillation.
    Gupta MS; Gupta D
    J Assoc Physicians India; 1992 Nov; 40(11):737-9. PubMed ID: 1307536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low- and medium-dose diltiazem in chronic atrial fibrillation: comparison with digoxin and correlation with drug plasma levels.
    Maragno I; Santostasi G; Gaion RM; Trento M; Grion AM; Miraglia G; Dalla Volta S
    Am Heart J; 1988 Aug; 116(2 Pt 1):385-92. PubMed ID: 3400564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation.
    Innes GD; Vertesi L; Dillon EC; Metcalfe C
    Ann Emerg Med; 1997 Jan; 29(1):126-34. PubMed ID: 8998091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
    Platia EV; Michelson EL; Porterfield JK; Das G
    Am J Cardiol; 1989 Apr; 63(13):925-9. PubMed ID: 2564725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.
    Beasley R; Smith DA; McHaffie DJ
    Br Med J (Clin Res Ed); 1985 Jan; 290(6461):9-11. PubMed ID: 3917348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis.
    Panidis IP; Morganroth J; Baessler C
    Am J Cardiol; 1983 Dec; 52(10):1197-201. PubMed ID: 6359848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reconversion of long-standing atrial flutter and fibrillation to sinus rhythm, with oral verapamil and digoxin. Description of 3 cases].
    Mazzoli V; Malmusi A; Scalori G
    G Clin Med; 1985; 66(1-2):57-61. PubMed ID: 4007343
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation.
    Lewis RV; Laing E; Moreland TA; Service E; McDevitt DG
    Eur Heart J; 1988 Mar; 9(3):279-83. PubMed ID: 3289931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The chronotropic and hemodynamic effects of finoptin in patients with a permanent form of atrial fibrillation].
    Dobrotvorskaia TE; Kazakevich EV; Kuznetsova LA; Kotlov AP
    Ter Arkh; 1992; 64(8):34-6. PubMed ID: 1440391
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation.
    Yahalom J; Klein HO; Kaplinsky E
    Chest; 1977 May; 71(5):592-6. PubMed ID: 856557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation.
    Bøtker HE; Toft P; Klitgaard NA; Simonsen EE
    Br Heart J; 1991 Jun; 65(6):337-41. PubMed ID: 2054244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of labetalol in chronic atrial fibrillation.
    Wong CK; Lau CP; Leung WH; Cheng CH
    Am J Cardiol; 1990 Nov; 66(17):1212-5. PubMed ID: 2239725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy of Univer and conventional verapamil in the control of ventricular response in atrial fibrillation.
    Hogg KJ; Hornung RS; Hillis WS
    Br J Clin Pract Suppl; 1988 Apr; 60():38-44. PubMed ID: 3151270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.